Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Correlates of smoker identity among intermittent and light daily young adult smokers: Findings from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study.

Smith DM, O'Connor RJ, Collins RL, Hyland AJ, Kozlowski LT.

Addict Behav. 2019 Jun 24;98:106034. doi: 10.1016/j.addbeh.2019.106034. [Epub ahead of print]

PMID:
31301643
2.

Awareness and interest in lung cancer screening among current and former smokers: findings from the ITC United States Survey.

Sharma A, Kasza K, Hyland A, Cummings KM, Bansal-Travers M, Fong GT, O'Connor RJ.

Cancer Causes Control. 2019 Jul;30(7):733-745. doi: 10.1007/s10552-019-01186-y. Epub 2019 May 23.

PMID:
31123842
3.

Understanding the Financial Consequences of Smoking During Cancer Treatment in the Era of Value-Based Medicine.

Petrucci CM, Hyland A.

JAMA Netw Open. 2019 Apr 5;2(4):e191713. doi: 10.1001/jamanetworkopen.2019.1713. No abstract available.

PMID:
30951153
4.

Harm perceptions and tobacco use initiation among youth in Wave 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study.

Strong DR, Leas E, Elton-Marshall T, Wackowski OA, Travers M, Bansal-Travers M, Hyland A, White M, Noble M, Cummings KM, Taylor K, Kaufman AR, Choi K, Pierce JP.

Prev Med. 2019 Jun;123:185-191. doi: 10.1016/j.ypmed.2019.03.017. Epub 2019 Mar 13.

PMID:
30878572
5.

Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Chang CM, Rostron BL, Chang JT, Corey CG, Kimmel HL, Sosnoff CS, Goniewicz ML, Edwards KC, Hatsukami DK, Wang Y, Del Valle-Pinero AY, Yang M, Travers MJ, Arnstein S, Taylor K, Conway K, Ambrose BK, Borek N, Hyland A, Wang L, Blount BC, van Bemmel DM.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):943-953. doi: 10.1158/1055-9965.EPI-18-0539. Epub 2019 Feb 7.

PMID:
30733305
6.

Longitudinal e-cigarette and cigarette use among US youth in the PATH Study (2013-2015).

Stanton CA, Bansal-Travers M, Johnson AL, Sharma E, Katz L, Ambrose BK, Silveira ML, Day H, Sargent J, Borek N, Compton WM, Johnson S, Kimmel H, Kaufman AR, Limpert J, Abrams D, Cummings KM, Goniewicz ML, Tanski S, Travers MJ, Hyland AJ, Pearson JL.

J Natl Cancer Inst. 2019 Jan 25. doi: 10.1093/jnci/djz006. [Epub ahead of print]

PMID:
30689915
7.

Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.

Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, Wang L, Christensen C, Ambrose B, Borek N, van Bemmel D, Konkel K, Erives G, Stanton CA, Lambert E, Kimmel HL, Hatsukami D, Hecht SS, Niaura RS, Travers M, Lawrence C, Hyland AJ.

JAMA Netw Open. 2018 Dec 7;1(8):e185937. doi: 10.1001/jamanetworkopen.2018.5937.

8.

Youth perception of harm and addictiveness of tobacco products: Findings from the Population Assessment of Tobacco and Health Study (Wave 1).

Strong DR, Messer K, White M, Shi Y, Noble M, Portnoy DB, Persoskie A, Kaufman AR, Choi K, Carusi C, Bansal-Travers M, Hyland A, Pierce J.

Addict Behav. 2019 May;92:128-135. doi: 10.1016/j.addbeh.2018.12.005. Epub 2019 Jan 3.

PMID:
30623806
9.

Mental Health Problems and Onset of Tobacco Use Among 12- to 24-Year-Olds in the PATH Study.

Green VR, Conway KP, Silveira ML, Kasza KA, Cohn A, Cummings KM, Stanton CA, Callahan-Lyon P, Slavit W, Sargent JD, Hilmi N, Niaura RS, Reissig CJ, Lambert E, Zandberg I, Brunette MF, Tanski SE, Borek N, Hyland AJ, Compton WM.

J Am Acad Child Adolesc Psychiatry. 2018 Dec;57(12):944-954.e4. doi: 10.1016/j.jaac.2018.06.029. Epub 2018 Oct 4.

PMID:
30522740
10.

Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Wang Y, Wong LY, Meng L, Pittman EN, Trinidad DA, Hubbard KL, Etheredge A, Del Valle-Pinero AY, Zamoiski R, van Bemmel DM, Borek N, Patel V, Kimmel HL, Conway KP, Lawrence C, Edwards KC, Hyland A, Goniewicz ML, Hatsukami D, Hecht SS, Calafat AM.

Environ Int. 2019 Feb;123:201-208. doi: 10.1016/j.envint.2018.11.068. Epub 2018 Dec 6.

11.

U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the path study.

Fong GT, Elton-Marshall T, Driezen P, Kaufman AR, Cummings KM, Choi K, Kwan J, Koblitz A, Hyland A, Bansal-Travers M, Carusi C, Thompson ME.

Addict Behav. 2019 Apr;91:180-187. doi: 10.1016/j.addbeh.2018.11.023. Epub 2018 Nov 17.

PMID:
30502927
12.

Associations of risk factors of e-cigarette and cigarette use and susceptibility to use among baseline PATH study youth participants (2013-2014).

Sawdey MD, Day HR, Coleman B, Gardner LD, Johnson SE, Limpert J, Hammad HT, Goniewicz ML, Abrams DB, Stanton CA, Pearson JL, Kaufman AR, Kimmel HL, Delnevo CD, Compton WM, Bansal-Travers M, Niaura RS, Hyland A, Ambrose BK.

Addict Behav. 2019 Apr;91:51-60. doi: 10.1016/j.addbeh.2018.11.027. Epub 2018 Nov 17.

PMID:
30473246
13.

Correlates of Transitions in Tobacco Product Use by U.S. Adult Tobacco Users between 2013⁻2014 and 2014⁻2015: Findings from the PATH Study Wave 1 and Wave 2.

Kasza KA, Coleman B, Sharma E, Conway KP, Cummings KM, Goniewicz ML, Niaura RS, Lambert EY, Schneller LM, Feirman SP, Donaldson EA, Cheng YC, Murphy I, Pearson JL, Trinidad DR, Bansal-Travers M, Elton-Marshall T, Gundersen DA, Stanton CA, Abrams DB, Fong GT, Borek N, Compton WM, Hyland AJ.

Int J Environ Res Public Health. 2018 Nov 14;15(11). pii: E2556. doi: 10.3390/ijerph15112556.

14.

Transitions in Tobacco Product Use by U.S. Adults between 2013⁻2014 and 2014⁻2015: Findings from the PATH Study Wave 1 and Wave 2.

Kasza KA, Borek N, Conway KP, Goniewicz ML, Stanton CA, Sharma E, Fong GT, Abrams DB, Coleman B, Schneller LM, Lambert EY, Pearson JL, Bansal-Travers M, Murphy I, Cheng YC, Donaldson EA, Feirman SP, Gravely S, Elton-Marshall T, Trinidad DR, Gundersen DA, Niaura RS, Cummings KM, Compton WM, Hyland AJ.

Int J Environ Res Public Health. 2018 Nov 9;15(11). pii: E2515. doi: 10.3390/ijerph15112515.

15.

Youth Access to Tobacco Products in the United States: Findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) Study.

Tanski S, Emond J, Stanton C, Kirchner T, Choi K, Yang L, Ryant C, Robinson J, Hyland A, Emond J, Stanton C, Kirchner T, Choi K, Yang L, Ryant C, Robinson J, Hyland A.

Nicotine Tob Res. 2018 Nov 8. doi: 10.1093/ntr/nty238. [Epub ahead of print]

PMID:
30407588
16.

Population Assessment of Tobacco and Health (PATH) reliability and validity study: selected reliability and validity estimates.

Tourangeau R, Yan T, Sun H, Hyland A, Stanton CA.

Tob Control. 2018 Oct 8. pii: tobaccocontrol-2018-054561. doi: 10.1136/tobaccocontrol-2018-054561. [Epub ahead of print]

PMID:
30297373
17.

Using a Smoking Cessation Quitline to Promote Lung Cancer Screening.

Sharma A, Bansal-Travers M, Celestino P, Fine J, Reid ME, Hyland A, O'Connor R.

Am J Health Behav. 2018 Nov 1;42(6):85-100. doi: 10.5993/AJHB.42.6.9.

PMID:
30158004
18.

Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study.

Silveira ML, Conway KP, Green VR, Kasza KA, Sargent JD, Borek N, Stanton CA, Cohn A, Hilmi N, Cummings KM, Niaura RS, Lambert EY, Brunette MF, Zandberg I, Tanski SE, Reissig CJ, Callahan-Lyon P, Slavit WI, Hyland AJ, Compton WM.

Drug Alcohol Depend. 2018 Oct 1;191:25-36. doi: 10.1016/j.drugalcdep.2018.06.018. Epub 2018 Jul 25.

PMID:
30077053
19.

Examining the Association between Body Burdens of Harmful Chemicals and Heaviness of Marijuana Smoking.

Wei B, Smith D, O'Connor R, Travers MJ, Hyland A.

Chem Res Toxicol. 2018 Aug 20;31(8):643-645. doi: 10.1021/acs.chemrestox.8b00160. Epub 2018 Aug 6.

PMID:
30052028
20.

Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1 and 2 (2013-2015).

Coleman B, Rostron B, Johnson SE, Persoskie A, Pearson J, Stanton C, Choi K, Anic G, Goniewicz ML, Cummings KM, Kasza KA, Silveira ML, Delnevo C, Niaura R, Abrams DB, Kimmel HL, Borek N, Compton WM, Hyland A.

Tob Control. 2019 Jan;28(1):50-59. doi: 10.1136/tobaccocontrol-2017-054174. Epub 2018 Apr 25.

21.

Association Between Receptivity to Tobacco Advertising and Progression to Tobacco Use in Youth and Young Adults in the PATH Study.

Pierce JP, Sargent JD, Portnoy DB, White M, Noble M, Kealey S, Borek N, Carusi C, Choi K, Green VR, Kaufman AR, Leas E, Lewis MJ, Margolis KA, Messer K, Shi Y, Silveira ML, Snyder K, Stanton CA, Tanski SE, Bansal-Travers M, Trinidad D, Hyland A.

JAMA Pediatr. 2018 May 1;172(5):444-451. doi: 10.1001/jamapediatrics.2017.5756.

22.

Urinary Metabolite Levels of Flame Retardants in Electronic Cigarette Users: A Study Using the Data from NHANES 2013-2014.

Wei B, Goniewicz ML, O'Connor RJ, Travers MJ, Hyland AJ.

Int J Environ Res Public Health. 2018 Jan 25;15(2). pii: E201. doi: 10.3390/ijerph15020201.

23.

Evaluation of a Dedicated Tobacco Cessation Support Service for Thoracic Cancer Center Patients.

Amato KA, Reid ME, Ochs-Balcom HM, Giovino GA, Bansal-Travers M, Warren GW, Mahoney MC, Hyland AJ.

J Public Health Manag Pract. 2018 Sep/Oct;24(5):E12-E19. doi: 10.1097/PHH.0000000000000674.

PMID:
29278577
24.

US Adult Cigar Smoking Patterns, Purchasing Behaviors, and Reasons for Use According to Cigar Type: Findings From the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

Corey CG, Holder-Hayes E, Nguyen AB, Delnevo CD, Rostron BL, Bansal-Travers M, Kimmel HL, Koblitz A, Lambert E, Pearson JL, Sharma E, Tworek C, Hyland AJ, Conway KP, Ambrose BK, Borek N.

Nicotine Tob Res. 2018 Nov 15;20(12):1457-1466. doi: 10.1093/ntr/ntx209.

PMID:
29059423
25.

Co-occurrence of tobacco product use, substance use, and mental health problems among youth: Findings from wave 1 (2013-2014) of the population assessment of tobacco and health (PATH) study.

Conway KP, Green VR, Kasza KA, Silveira ML, Borek N, Kimmel HL, Sargent JD, Stanton CA, Lambert E, Hilmi N, Reissig CJ, Jackson KJ, Tanski SE, Maklan D, Hyland AJ, Compton WM.

Addict Behav. 2018 Jan;76:208-217. doi: 10.1016/j.addbeh.2017.08.009. Epub 2017 Aug 18.

PMID:
28846942
26.

Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14).

Pearson JL, Johnson AL, Johnson SE, Stanton CA, Villanti AC, Niaura RS, Glasser AM, Wang B, Abrams DB, Cummings KM, Hyland A.

Addiction. 2018 Jan;113(1):113-124. doi: 10.1111/add.13952. Epub 2017 Sep 6.

27.

Indicators of dependence for different types of tobacco product users: Descriptive findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) study.

Strong DR, Pearson J, Ehlke S, Kirchner T, Abrams D, Taylor K, Compton WM, Conway KP, Lambert E, Green VR, Hull LC, Evans SE, Cummings KM, Goniewicz M, Hyland A, Niaura R.

Drug Alcohol Depend. 2017 Sep 1;178:257-266. doi: 10.1016/j.drugalcdep.2017.05.010. Epub 2017 Jun 28.

PMID:
28675817
28.

Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

Coleman BN, Rostron B, Johnson SE, Ambrose BK, Pearson J, Stanton CA, Wang B, Delnevo C, Bansal-Travers M, Kimmel HL, Goniewicz ML, Niaura R, Abrams D, Conway KP, Borek N, Compton WM, Hyland A.

Tob Control. 2017 Dec;26(e2):e117-e126. doi: 10.1136/tobaccocontrol-2016-053462. Epub 2017 Jun 17.

PMID:
28624763
29.

Co-occurrence of tobacco product use, substance use, and mental health problems among adults: Findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) Study.

Conway KP, Green VR, Kasza KA, Silveira ML, Borek N, Kimmel HL, Sargent JD, Stanton C, Lambert E, Hilmi N, Reissig CJ, Jackson KJ, Tanski SE, Maklan D, Hyland AJ, Compton WM.

Drug Alcohol Depend. 2017 Aug 1;177:104-111. doi: 10.1016/j.drugalcdep.2017.03.032. Epub 2017 May 30.

30.

Receptivity to Tobacco Advertising and Susceptibility to Tobacco Products.

Pierce JP, Sargent JD, White MM, Borek N, Portnoy DB, Green VR, Kaufman AR, Stanton CA, Bansal-Travers M, Strong DR, Pearson JL, Coleman BN, Leas E, Noble ML, Trinidad DR, Moran MB, Carusi C, Hyland A, Messer K.

Pediatrics. 2017 Jun;139(6). pii: e20163353. doi: 10.1542/peds.2016-3353.

31.

Susceptibility to tobacco product use among youth in wave 1 of the population Assessment of tobacco and health (PATH) study.

Trinidad DR, Pierce JP, Sargent JD, White MM, Strong DR, Portnoy DB, Green VR, Stanton CA, Choi K, Bansal-Travers M, Shi Y, Pearson JL, Kaufman AR, Borek N, Coleman BN, Hyland A, Carusi C, Kealey S, Leas E, Noble ML, Messer K.

Prev Med. 2017 Aug;101:8-14. doi: 10.1016/j.ypmed.2017.05.010. Epub 2017 May 17.

32.

Engagement With Online Tobacco Marketing and Associations With Tobacco Product Use Among U.S. Youth.

Soneji S, Pierce JP, Choi K, Portnoy DB, Margolis KA, Stanton CA, Moore RJ, Bansal-Travers M, Carusi C, Hyland A, Sargent J.

J Adolesc Health. 2017 Jul;61(1):61-69. doi: 10.1016/j.jadohealth.2017.01.023. Epub 2017 Mar 28.

33.

Flavored Tobacco Product Use in Youth and Adults: Findings From the First Wave of the PATH Study (2013-2014).

Villanti AC, Johnson AL, Ambrose BK, Cummings KM, Stanton CA, Rose SW, Feirman SP, Tworek C, Glasser AM, Pearson JL, Cohn AM, Conway KP, Niaura RS, Bansal-Travers M, Hyland A.

Am J Prev Med. 2017 Aug;53(2):139-151. doi: 10.1016/j.amepre.2017.01.026. Epub 2017 Mar 16.

34.

Attitudes and experiences with secondhand smoke and smoke-free policies among subsidised and market-rate multiunit housing residents living in six diverse communities in the USA.

Gentzke AS, Hyland A, Kiviniemi M, Travers MJ.

Tob Control. 2018 Mar;27(2):194-202. doi: 10.1136/tobaccocontrol-2016-053374. Epub 2017 Mar 16.

35.

Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.

Kasza KA, Ambrose BK, Conway KP, Borek N, Taylor K, Goniewicz ML, Cummings KM, Sharma E, Pearson JL, Green VR, Kaufman AR, Bansal-Travers M, Travers MJ, Kwan J, Tworek C, Cheng YC, Yang L, Pharris-Ciurej N, van Bemmel DM, Backinger CL, Compton WM, Hyland AJ.

N Engl J Med. 2017 Jan 26;376(4):342-353. doi: 10.1056/NEJMsa1607538. Erratum in: N Engl J Med. 2018 Feb 1;378(5):492.

36.

Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, Cinciripini P, Collins B, David S, Davis J, Hitsman B, Hyland A, Lang M, Leischow S, Park ER, Purcell WT, Selzle J, Silber A, Spencer S, Tanvetyanon T, Tiep B, Tindle HA, Tucker-Seeley R, Urbanic J, Hooper MW, Weksler B, Whitlock CW, Wood DE, Burns J, Scavone J.

J Natl Compr Canc Netw. 2016 Nov;14(11):1430-1468.

PMID:
27799513
37.

Cross-country comparison of smokers' reasons for thinking about quitting over time: findings from the International Tobacco Control Four Country Survey (ITC-4C), 2002-2015.

Kasza KA, Hyland AJ, Borland R, McNeill A, Fong GT, Carpenter MJ, Partos T, Cummings KM.

Tob Control. 2017 Nov;26(6):641-648. doi: 10.1136/tobaccocontrol-2016-053299. Epub 2016 Oct 26.

38.

Association between use of flavoured tobacco products and quit behaviours: findings from a cross-sectional survey of US adult tobacco users.

Smith DM, Bansal-Travers M, Huang J, Barker D, Hyland AJ, Chaloupka F.

Tob Control. 2016 Nov;25(Suppl 2):ii73-ii80. doi: 10.1136/tobaccocontrol-2016-053313. Epub 2016 Oct 5.

39.

Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Hyland A, Ambrose BK, Conway KP, Borek N, Lambert E, Carusi C, Taylor K, Crosse S, Fong GT, Cummings KM, Abrams D, Pierce JP, Sargent J, Messer K, Bansal-Travers M, Niaura R, Vallone D, Hammond D, Hilmi N, Kwan J, Piesse A, Kalton G, Lohr S, Pharris-Ciurej N, Castleman V, Green VR, Tessman G, Kaufman A, Lawrence C, van Bemmel DM, Kimmel HL, Blount B, Yang L, O'Brien B, Tworek C, Alberding D, Hull LC, Cheng YC, Maklan D, Backinger CL, Compton WM.

Tob Control. 2017 Jul;26(4):371-378. doi: 10.1136/tobaccocontrol-2016-052934. Epub 2016 Aug 8.

40.

Inhaled medication usage in post-menopausal women and lifetime tobacco smoke exposure: The Women's Health Initiative Observational Study.

Piazza KM, Wactawski-Wende J, DeBon MW, Hovey KM, Rivard CL, Smith DM, Hyland AJ.

Maturitas. 2016 Aug;90:42-8. doi: 10.1016/j.maturitas.2016.05.008. Epub 2016 May 17.

PMID:
27282793
41.

The Association of Exposure to Point-of-Sale Tobacco Marketing with Quit Attempt and Quit Success: Results from a Prospective Study of Smokers in the United States.

Siahpush M, Shaikh RA, Smith D, Hyland A, Cummings KM, Kessler AS, Dodd MD, Carlson L, Meza J, Wakefield M.

Int J Environ Res Public Health. 2016 Feb 6;13(2):203. doi: 10.3390/ijerph13020203.

42.

Associations between lifetime tobacco exposure with infertility and age at natural menopause: the Women's Health Initiative Observational Study.

Hyland A, Piazza K, Hovey KM, Tindle HA, Manson JE, Messina C, Rivard C, Smith D, Wactawski-Wende J.

Tob Control. 2016 Nov;25(6):706-714. doi: 10.1136/tobaccocontrol-2015-052510. Epub 2015 Dec 14.

PMID:
26666428
43.

Flavored Tobacco Product Use Among US Youth Aged 12-17 Years, 2013-2014.

Ambrose BK, Day HR, Rostron B, Conway KP, Borek N, Hyland A, Villanti AC.

JAMA. 2015 Nov 3;314(17):1871-3. doi: 10.1001/jama.2015.13802. No abstract available.

44.

Is the smoke-free protections glass half full or half empty?

Hyland A.

Tob Control. 2015 Oct;24(e3):e178. doi: 10.1136/tobaccocontrol-2015-052663. No abstract available.

PMID:
26420597
45.

Point-of-Sale Cigarette Marketing, Urge to Buy Cigarettes, and Impulse Purchases of Cigarettes: Results From a Population-Based Survey.

Siahpush M, Shaikh RA, Hyland A, Smith D, Sikora Kessler A, Meza J, Wan N, Wakefield M.

Nicotine Tob Res. 2016 May;18(5):1357-62. doi: 10.1093/ntr/ntv181. Epub 2015 Sep 16.

46.

Associations between perceptions of e-cigarette advertising and interest in product trial amongst US adult smokers and non-smokers: results from an internet-based pilot survey.

Smith DM, Bansal-Travers M, O'Connor RJ, Goniewicz ML, Hyland A.

Tob Induc Dis. 2015 Jun 12;13(1):14. doi: 10.1186/s12971-015-0039-6. eCollection 2015.

47.

Tobacco Cessation May Improve Lung Cancer Patient Survival.

Dobson Amato KA, Hyland A, Reed R, Mahoney MC, Marshall J, Giovino G, Bansal-Travers M, Ochs-Balcom HM, Zevon MA, Cummings KM, Nwogu C, Singh AK, Chen H, Warren GW, Reid M.

J Thorac Oncol. 2015 Jul;10(7):1014-9. doi: 10.1097/JTO.0000000000000578.

48.

The association of point-of-sale cigarette marketing with cravings to smoke: results from a cross-sectional population-based study.

Siahpush M, Shaikh RA, Cummings KM, Hyland A, Dodd M, Carlson L, Kessler AS, Meza J, Wan N, Wakefield M.

Tob Control. 2016 Jul;25(4):402-5. doi: 10.1136/tobaccocontrol-2015-052253. Epub 2015 May 29.

49.

A Follow-Up Community Survey of Knowledge and Beliefs About Cancer and Genetics.

Sweeney SM, Hastrup JL, Hyland A, Rivard C.

J Cancer Educ. 2016 Jun;31(2):253-60. doi: 10.1007/s13187-015-0856-6.

50.

Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey.

Smith PH, Kasza KA, Hyland A, Fong GT, Borland R, Brady K, Carpenter MJ, Hartwell K, Cummings KM, McKee SA.

Nicotine Tob Res. 2015 Apr;17(4):463-72. doi: 10.1093/ntr/ntu212.

Supplemental Content

Loading ...
Support Center